A direct correlation between ZEB1 immunoreactivity and Gleason grade has been reported in human prostate tumors [23] and in bladder cancer, ZEB1 has been reported to be over-expressed and responsible for enhanced motility [18]. Here, ZEB1 is linked to urinary bladder carcinoma.